(Q37386059)
Statements
1 reference
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer (English)
1 reference
Bassel F El-Rayes
1 reference
Mark M Zalupski
1 reference
Stephanie G Manza
1 reference
Barbara Rusin
1 reference
Ann Marie Ferris
1 reference
Ulka Vaishampayan
1 reference
Lance K Heilbrun
1 reference
Raghu Venkatramanamoorthy
1 reference
Anthony F Shields
1 reference
Philip A Philip
1 reference
12 April 2007
1 reference
1 reference
283-289
1 reference
Identifiers
1 reference
1 reference
1 reference